DEVELOPMENT AND EVALUATION OF TASTE MASKED ORO-DISINTEGRATING TABLETS OF ITOPRIDE HCl USING DIFFERENT CO-PROCESSED EXCIPIENTS: PHARMACOKINETICS STUDY ON RABBITS

REHAB ABDELMONEM; MAHMOUD ELTAHAN; MOHAMED EL-NABARAWI

doi:10.22159/ijap.2022v14i3.44398

Authors

REHAB ABDELMONEM Department of Industrial Pharmacy, Faculty of Pharmacy, Misr University for Science and Technology, 6th October City, Egypt
MAHMOUD ELTAHAN Department of Industrial Pharmacy, Faculty of Pharmacy, Misr University for Science and Technology, 6th October City, Egypt
MOHAMED EL-NABARAWI Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt

DOI:

https://doi.org/10.22159/ijap.2022v14i3.44398

Keywords:

Itopride HCl, Solid dispersion, Solvent evaporation, Taste masking, In vivo evaluation, Prosolv SMCC 90®, Eudragit EPO®

Abstract

Objective: This study aimed to mask the bitter taste of itopride HCl using the solid dispersion method by solvent evaporation technique and formulate an oral disintegrating tablet (ODT) by direct compression method using different co-processed excipients.

Methods: Nine formulae of solid dispersion were prepared to mask the bitter taste of Itopride HCl using Eudragit EPO^® and mannitol at different ratios after compatibility studies using infrared spectroscopy (IR). The prepared formulae were subjected to different physicochemical characterization, in vivo taste evaluation, and drug content. The best-selected formulae were used to formulate 10 different ODTs. The prepared tablets were evaluated through hardness, drug content, in vivo-in vitro disintegration, IR, wetting time, and finally, dissolution studies. The selected formula was subjected to a pharmacokinetic study compared to the brand.

Results: F5, drug: Eudragit EPO^® (1:2) and F8, Drug: Mannitol: Eudragit EPO^® (1:1:2) formulae were selected as the best taste-masked formulae based on in vivo taste evaluation, which were used to formulate ten ODTs. The dissolution rate for the prepared ODTs was rapid if compared with the ordinary oral tablets. Statistical significance was obtained using one-way ANOVA among ODT formulae. The optimum tablet Prosolv SMCC 90^® based formula (T10) had friability 0.15, wetting time 4±0.35 sec, in vitro dissolution 100.08±0.028% just after 2 min, where the in vitro disintegration time and in vivo disintegration time were 4±0.12 sec and 12±0.049 sec respectively. The relative bioavailability of ODT containing Prosolv SMCC 90^®was increased significantly compared to the brand.

Conclusion: The obtained results successfully confirmed the potential of the promising Prosolv SMCC 90^® based formula (T10) to produce rapid onset action and in-time drug release instead of ordinary tablets containing itopride HCl and that provide by-passing the excessive degradation of drug by first-pass metabolism increasing the oral bioavailability from 60% of marketed drug Ganaton^® to 88% for the prepared ODT (T10).

Downloads

Download data is not yet available.

References

Abid S, Jafri W, Zaman MU, Bilal R, Awan S, Abbas A. Itopride for gastric volume, gastric emptying and drinking capacity in functional dyspepsia. World J Gastrointest Pharmacol Ther. 2017;8(1):74-80. doi: 10.4292/wjgpt.v8.i1.74, PMID 28217377.

Talley NJ, Goodsall T, Potter M. Functional dyspepsia. Aust Prescr. 2017;40(6):209-13. doi: 10.18773/austprescr.2017.066, PMID 29375182.

Torne SR, AS, CSN. Ranitidine controlled release anti-reflux suspension for gastro-oesophageal reflux disease and it’s in vitro evaluation. Int J Appl Pharm. 2019;11(1):74-81. doi: 10.22159/ijap.2019v11i1.28754.

Koul RK, Parveen S, Lahdol P, Rasheed PS, Shah NA. Prevalence and risk factors of gastroesophageal reflux disease (GERD) in adult kashmiri population. Int J Pharm Pharm Sci 2018;10(8):62-6. doi: 10.22159/ijpps.2018v10i8.25894.

Beakawi Al-Hashemi HM, Baghabra Al-Amoudi OS. A review on the angle of repose of granular materials. Powder Technol. 2018;330:397-417. doi: 10.1016/j.powtec.2018.02.003.

Basalious EB, Abdullah A, Ibrahim M. Utility of mannitol and citric acid for enhancing the solubilizing and taste-masking properties of β-cyclodextrin: development of fast-dissolving tablets containing an extremely bitter drug. J Pharm Innov. 2014;9(4):309-20. doi: 10.1007/s12247-014-9196-z.

Zhang X, Qi J, Zhang L, Zhang Y. A randomized controlled trial on itopride in the treatment of patients with irritable bowel syndrome with diarrhea accompanied by abdominal distension. Int J Clin Exp Med. 2019;12(9):11618-24.

Khan A, Nazir S, Alyami HS, Ullah A. SeDeM-ODT expert system: A solution to challenges in characterization of pharmaceutical powders and powdered material. Adv Funct Mater. 2020.

Rao MR, Shelar SU, Yunusi A. Controlled release floating oral in situ gel of itopride hydrochloride using pH-sensitive polymer. Int J Pharm Pharm Sci. 2014;6:338-43.

Mushiroda T, Douya R, Takahara E, Nagata O. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. Drug Metab Dispos. 2000;28(10):1231-7. PMID 10997945.

Adriany R, Anwar E, Andrajati R. Hanafi M. Formulation of orodispersible tablet of Luffa acutangula (L.) roxb using novel co-processed via spray dried excipient. Int J Pharm Pharm Sci. 2015;7(1):124-9.

Kar M, Chourasiya Y, Maheshwari R, Tekade RK. Current developments in excipient science: implication of quantitative selection of each excipient in product development. Basic Fundamentals of Drug Delivery. Elsevier; 2019. p. 29-83.

Chowdary K, Ramya K. Recent research on co-processed excipients for direct compression-a review. Pharm Globale. 2013;4(2):1.

Garg N, Dureja H, Kaushik D. co-processed excipients: A patent review. Recent Pat Drug Deliv Formul. 2013;7(1):73-83. doi: 10.2174/187221113804805847, PMID 22974169.

Lieberman HA, Lachman L, Schwartz JB. Pharmaceutical dosage forms: tablets: M. Dekker; 1980.

Hassan M, Shahbaz N, Khan SI, Khan I. Formulation and evaluation of taste-masked orally disintegrating tablets of itopride HCl using hydrophillic polymers as drug carrier. Lat Am J Pharm. 2015;34(7):1364-72.

Sousa e Silva JP, Splendor D, Gonçalves IM, Costa P, Sousa Lobo JM. Note on the measurement of bulk density and tapped density of powders according to the European Pharmacopeia. AAPS PharmSciTech. 2013;14(3):1098-100. doi: 10.1208/s12249-013-9994-5, PMID 23818081.

Xu G, Li M, Lu P. Experimental investigation on flow properties of different biomass and torrefied biomass powders. Biomass Bioenergy. 2019;122:63-75. doi: 10.1016/ j.biombioe. 2019.01.016.

Suchicital LG, Gujral H, Speroni KG, Eldridge D, Atherton M. Prospective, randomized, pilot study evaluating the effect of ice chips administration versus none on the bitterness of crushed medications in postoperative bariatric patients. Bariatr Nurs Surg Patient Care. 2011;6(1):15-20. doi: 10.1089/bar.2011.9985.

Alyami H, Dahmash E, Bowen J, Mohammed AR. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug. Plos One. 2017;12(6):e0178772. doi: 10.1371/journal.pone.0178772, PMID 28609454.

Pare A, Yadav S, Patil U. Formulation and evaluation of effervescent floating tablet of amlodipine besylate. Res J Pharm Technol. 2008;1(3):255-8.

Osei Yeboah F, Sun CC. Validation and applications of an expedited tablet friability method. Int J Pharm. 2015;484(1-2):146-55. doi: 10.1016/j.ijpharm.2015.02.061, PMID 25724139.

Abdelmonem R, Abdellatif MM, Al-Samadi IEI, El-Nabarawi MA. Formulation and evaluation of baclofen-meloxicam orally disintegrating tablets (ODTs) using co-processed excipients and improvement of ODTs performance using Six Sigma method. Drug Des Devel Ther. 2021;15:4383-402. doi: 10.2147/DDDT.S327193, PMID 34690500.

Basaleh S, Bisharat L, Cespi M, Berardi A. Temperature: an overlooked factor in tablet disintegration. Eur J Pharm Sci. 2020;151:105388. doi: 10.1016/j.ejps.2020.105388.

Begum S, Basha SAA, Fatima S. Formulation and in vitro evaluation of mouth dissolving tablets of amlodipine and rosuvastatin. Int J Curr Pharm Res. 2015;7:88-91.

Meszaros LA, Galata DL, Madarász L, Köte A, Csorba K, Dávid AZ, Domokos A, Szabó E, Nagy B, Marosi G, Farkas A, Nagy ZK. Digital UV/vis imaging: A rapid PAT tool for crushing strength, drug content and particle size distribution determination in tablets. Int J Pharm. 2020;578:119174. doi: 10.1016/j.ijpharm.2020.119174.

Shah S, Madan S, Agrawal S. Formulation and evaluation of microsphere based oro dispersible tablets of itopride hcl. Daru. 2012;20(1):24. doi: 10.1186/2008-2231-20-24, PMID 23351176.

Albash R, Fahmy AM, Hamed MIA, Darwish KM, El-Dahmy RM. Spironolactone hyaluronic acid-enriched cerosomes (HAECs) for topical management of hirsutism: in silico studies, statistical optimization, ex vivo, and in vivo studies. Drug Deliv. 2021;28(1):2289-300. doi: 10.1080/10717544.2021.1989089, PMID 34726545.

Sisinthy SP, Duraipandi S, RAO NK, RAO MB. Determination and validation of a HPLC method with UV detection of itopride hydrochloride in human serum. Int J Pharm Sci. 2015;7:246-9.

Kacso I, Rus LM, Martin F, Miclaus M, Filip X, Dan M. Solid-state compatibility studies of ketoconazole-fumaric acid co-crystal with tablet excipients. J Therm Anal Calorim. 2021;143(5):3499-506. doi: 10.1007/s10973-020-09340-4.

Shah S, Madan S, Agrawal S. Formulation and evaluation of microsphere-based orodispersible tablets of itopride hcl. Daru. 2012;20(1):24. doi: 10.1186/2008-2231-20-24, PMID 23351176.

Takeuchi Y, Tomita T, Kuroda J, Kageyu A, Yonekura C, Hiramura Y, Tahara K, Takeuchi H. Characterization of mannitol granules and powder: A comparative study using two flowability testers. Int J Pharm. 2018;547(1-2):106-13. doi: 10.1016/j.ijpharm.2018.05.061, PMID 29803796.

Yan YD, Woo JS, Kang JH, Yong CS, Choi HG. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Biol Pharm Bull. 2010;33(8):1364-70. doi: 10.1248/bpb.33.1364, PMID 20686233.

Malaak FA. A pharmaceutical study on a sparingly soluble drug. CU Theses; 2019.

Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol. 2002;122(2-3):188-98. doi: 10.1016/S0032-5910(01)00415-6.

Madathilethu J, Roberts M, Peak M, Blair J, Prescott R, Ford JL. Content uniformity of quartered hydrocortisone tablets in comparison with mini-tablets for paediatric dosing. BMJ Paediatr Open. 2018;2(1):e000198. doi: 10.1136/bmjpo-2017-000198, PMID 29637186.

Liew KB, Peh KK. Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet. Arch Pharm Res. 2021;44(8):1-10. doi: 10.1007/s12272-014-0542-y, PMID 25579848.

Moqbel HA, ElMeshad AN, El-Nabarawi MA. A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in vivo evaluation. Drug Deliv. 2016;23(8):2998-3007. doi: 10.3109/10717544.2016.1138340, PMID 26828616.

Shoman NAI. A pharmaceutical study on fast melt tablets. CU Theses; 2018.

Teaima MH, Abdel-Haleem KM, Osama R, El-Nabarawi MA, Elnahas OS. A promising single oral disintegrating tablet for co-delivery of pitavastatin calcium and lornoxicam using co-processed excipients: formulation, characterization and pharmacokinetic study. Drug Des Devel Ther. 2021;15:4229-42. doi: 10.2147/DDDT.S332729, PMID 34675486.

Zaid AN, Al-Ramahi RJ, Ghoush AA, Qaddumi A, Zaaror YA. Weight and content uniformity of lorazepam half-tablets: A study of correlation of a low drug content product. Saudi Pharm J. 2013;21(1):71-5. doi: 10.1016/j.jsps.2011.12.009, PMID 23960821.

Kasperek R, Polski A, Zimmer Ł, Poleszak E. Release kinetics of papaverine hydrochloride from tablets with different excipients. Sci Pharm. 2014;82(3):684-96. doi: 10.3797/scipharm.1310-19, PMID 25853076.

Naguib MJ, Makhlouf AIA. Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study. Drug Deliv. 2021;28(1):1301-11. doi: 10.1080/10717544.2021.1938755, PMID 34176378.

Al-Samadi IEI. Formulation, evaluation, and improvement of tablet performance of a model drug. CU Theses; 2019.

Shirwaikar A, Joseph A, Srinivasan K, Jacob S. Novel co-processed excipients of mannitol and microcrystalline cellulose for preparing fast dissolving tablets of glipizide. Indian J Pharm Sci. 2007;69(5):633. doi: 10.4103/0250-474X.38467.

Wang J, Wen H, Desai D. Lubrication in tablet formulations. Eur J Pharm Biopharm. 2010;75(1):1-15. doi: 10.1016/j.ejpb.2010.01.007, PMID 20096779.

El-Nabarawi M, El-Monem R. Inas Essam Ibrahim Al-Samadi. Effect of co-process excipients in the formulation of ODTs using a model drug. Int J Pharm Sci Res. 2019;10(5):2172-81.

Abdolkarimi ES, Mosavi MR. Wavelet-adaptive neural subtractive clustering fuzzy inference system to enhance low-cost and high-speed INS/GPS navigation system. GPS Solut. 2020;24(2):1-17. doi: 10.1007/s10291-020-0951-y.

Gürel AE, Agbulut U, Bicen Y. Assessment of machine learning, time series, response surface methodology and empirical models in prediction of global solar radiation. J Cleaner Prod. 2020;277. doi: 10.1016/j.jclepro.2020.122353, PMID 122353.